1. ASSOCIATION BETWEEN PHENOTYPIC RESISTANCE PROFILE AND MUTATIONS WITH UNCERTAIN SIGNIFICANCE IN GENES ENCODING RESISTANCE TO ANTITUBERCULOSIS DRUGS IN MONO- AND POLYRESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES
- Author
-
M. Dohál, V. Dvořáková, M. Škereňová, E. Rasmussen, I. Porvazník, I. Solovič, and J. Mokrý
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Intro: Drug-resistant tuberculosis (DR-TB) has been declared to be a major contributor to antimicrobial resistance worldwide and remains a global public health concern. The genetic basis of antibiotic resistance in clinical DR Mycobactetium tuberculosis isolates has been widely studied and is predominantly attributed to mutations in specific genes. However, the role of some specific mutations in these genes has not yet been fully elucidated. This study aimed to characterize the mutations associated with resistance to first- and second-line anti-TB drugs classified in Group 3: Uncertain significance in the WHO catalogue and to investigate their relation with the phenotypic resistance profile. Methods: We performed whole genome sequencing of 50 strains of Mycobacterium tuberculosis phenotypically resistant to at least one anti-TB drug. All mutations in genes associated with resistance to first- and second-line anti-TB drugs were called and compared with the catalogue of mutations published by WHO. Findings: Variable sensitivities and specificities for genotype-phenotype correlation of resistance predictions ranging from 15% (pyrazinamide) to 92.7% (isoniazid) and 92.3% (izoniazid) to 100% (streptomycin) were obtained. Resistance conferring mutation was found in 22/50 (40%) isolates. Genotypic resistance to streptomycin was confirmed only in 11/30 phenotypically resistant isolates. For 6/30 isolates without a known mutation, we characterized a unique variants in the gidB gene (V77A; V202A; L35P; A119D; a-60c; c11-t) with uncertain significance in STM resistance. In 3 phenotypic PZA-monoresistant isolates we detected the mutation with uncertain significance in pncA (G162R) and kefB (A107V). All these mutations were present in the genome of phenotypically resistant isolates. Conclusion: In this study we characterized several mutations with uncertain significance in resistance to first- and second-line anti-TB drugs. Comparison of the phenotypic and genotypic resistance profile may contribute in the reclassification of some of these mutations with into the group of mutations associated with resistance.
- Published
- 2023
- Full Text
- View/download PDF